Here's What's Going On With Zomedica Shares - Benzinga

BenzingaEspañaItalia대한민국日本FrançaisMy AccountBenzinga EdgeBenzinga ResearchBenzinga ProLogin

• Get Benzinga Pro
• Data & APIs
• Events
• Premarket
• Advertise

ContributeEspañaItalia대한민국日本FrançaisLoginRegisterBenzinga

• Premium Services
• Financial News LatestEarningsGuidanceDividendsM&ABuybacksInterviewsManagementOfferingsIPOsInsider TradesBiotech/FDAPoliticsHealthcareSmall-Cap
• Markets Pre-MarketAfter HoursMoversETFsOptionsCryptocurrencyCommoditiesBondsFuturesMiningReal EstateVolatility
• Ratings Analyst ColorDowngradesUpgradesInitiationsPrice Target
• Investing Ideas Trade IdeasLong IdeasShort IdeasTechnicalsAnalyst RatingsAnalyst ColorLatest RumorsWhisper IndexStock of the DayBest Stocks & ETFsBest Penny StocksBest S&P 500 ETFsBest Swing Trade StocksBest Blue Chip StocksBest High-Volume Penny StocksBest Small Cap ETFsBest Stocks to Day TradeBest REITs
• Money InvestingCryptocurrencyMortgageInsuranceYieldPersonal FinanceForexStartup InvestingReal Estate InvestingProp TradingCredit CardsStock Brokers

Markets Pre-MarketAfter HoursMoversETFsOptionsCryptocurrencyCommoditiesBondsFuturesMiningReal EstateVolatilityRatings Analyst ColorDowngradesUpgradesInitiationsPrice TargetInvesting Ideas Trade IdeasLong IdeasShort IdeasTechnicalsAnalyst RatingsAnalyst ColorLatest RumorsWhisper IndexStock of the DayBest Stocks & ETFsBest Penny StocksBest S&P 500 ETFsBest Swing Trade StocksBest Blue Chip StocksBest High-Volume Penny StocksBest Small Cap ETFsBest Stocks to Day TradeBest REITsMoney InvestingCryptocurrencyMortgageInsuranceYieldPersonal FinanceForexStartup InvestingReal Estate InvestingProp TradingCredit CardsStock BrokersResearchMy StocksToolsFree Benzinga Pro Trial CalendarsAnalyst Ratings CalendarConference Call CalendarDividend CalendarEarnings CalendarEconomic CalendarFDA CalendarGuidance CalendarIPO CalendarM&A CalendarUnusual Options Activity CalendarSPAC CalendarStock Split CalendarTrade IdeasStock ReportsInsider TradesTrade Idea FeedAnalyst RatingsUnusual Options ActivityHeatmapsFree NewsletterGovernment TradesPerfect Stock PortfolioEasy Income PortfolioShort InterestMost ShortedLargest IncreaseLargest DecreaseCalculatorsMargin CalculatorForex Profit Calculator100x Options Profit CalculatorScreenersStock ScreenerTop Momentum StocksTop Quality StocksTop Value StocksTop Growth StocksCompare Best StocksBest Momentum StocksBest Quality StocksBest Value StocksBest Growth StocksRecentMarketsConnect With Us About Benzinga

• About Us
• Careers
• Advertise
• Contact Us

Market Resources

• Advanced Stock Screener Tools
• Options Trading Chain Analysis
• Comprehensive Earnings Calendar
• Dividend Investor Calendar and Alerts
• Economic Calendar and Market Events
• IPO Calendar and New Listings
• Market Outlook and Analysis
• Wall Street Analyst Ratings and Targets

Trading Tools & Education

• Benzinga Pro Trading Platform
• Options Trading Strategies and News
• Stock Market Trading Ideas and Analysis
• Technical Analysis Charts and Indicators
• Fundamental Analysis and Valuation
• Day Trading Guides and Strategies
• Live Investor Events
• Pre-market Stock Analysis and News
• Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Subscribe

• Terms & Conditions
• Do Not Sell My Personal Data/Privacy Policy
• Disclaimer
• Service Status
• Sitemap

© 2026 Benzinga | All Rights Reserved August 16, 2022 10:36 AM 1 min read

Here's What's Going On With Zomedica Shares

by Henry Khederian Benzinga Staff WriterFollow

Zomedica Corp (NASDAQ:ZOM) shares are trading lower by 13.9% to $0.32 Tuesday morning after the company reported second-quarter earnings results.

What Happened?

Zomedica reported quarterly losses of 1 cent per share. The company also reported $4.20 million in sales this quarter. This is a marked increase from sales of $15,690 in the same period last year.

Larry Heaton, Zomedica's Chief Executive Officer, commented: "The second quarter of 2022 was an exciting one for Zomedica as we both grew revenue organically and also executed on our acquisition strategy. We were pleased with our revenue growth to $4.2 million which reflects a 51% increase on a pro-forma basis, over the combined revenue of Zomedica and PulseVet as a standalone company of $2.8 million in the second quarter of last year.

See Also: Here's How Much You'd Have Now If You Invested $1,000 In Bitcoin, Ethereum And Dogecoin 5 Years Ago

According to data from Benzinga Pro, Zomedica has a 52-week high of $0.80 and a 52-week low of $0.18.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Posted In: Penny StocksSmall CapMoversTrading Ideaswhy it's movingBeat the Market With Our Free Pre-Market NewsletterEnter your email to get Benzinga's ultimate morning update: The PreMarket Activity NewsletterAdd CommentCommentsClose menuLoading...